One AI co‐scientist recommended drug is an FDA‐approved anti‐cancer treatment (Vorinostat) that reduced TGFβ‐induced chromatin structural changes by 91% and promoted liver parenchymal cell regeneration in microHOs. This evidence concerns the gene TGFB1 and cancer.